Lv3
250 积分 2024-06-29 加入
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
1个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
1个月前
已完结
Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin
5个月前
已完结
Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已完结
Role of major cardiovascular surgery-induced metabolic reprogramming in acute kidney injury in critical care
9个月前
已完结
Acute Kidney Injury
9个月前
已完结
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI
1年前
已完结
GLP-1 Receptor Agonist Outcomes, Safety, and BMI Change in a National Cohort of Dialysis Patients
1年前
已关闭
GLP-1 Receptor Agonist Outcomes, Safety, and BMI Change in a National Cohort of Dialysis Patients
1年前
已关闭
皖公网安备34019202002308
